Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Ankyloglossia

ClinicalTrials.gov lists 31 trials for Ankyloglossia or a narrower condition beneath it. Europa Life Sciences Limited has the most among industry and government lead sponsors, with 2.

MeSH D000072676 Stomatognathic Diseases C07
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1/2 Phase 1/2 1 Not applicable Not applicable 22 Observational Observational 8 Phase 1/2 Phase 1/2 1 Not applicable Not applicable 22 Observational Observational 8

Trials per phase (log scale)

31 of the 31 trials are tagged with Ankyloglossia itself; the rest are tagged with a narrower condition beneath it.

Get the Ankyloglossia report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Ankyloglossia trials start? (14)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.

Trials over time, by phase

  • Phase 1/2
  • Not applicable
  • Observational

Top of scale: 6

2007: 1 trials (Not applicable 1) 2011: 1 trials (Phase 1/2 1) 2012: 1 trials (Not applicable 1) 2014: 2 trials (Not applicable 2) 2015: 1 trials (Not applicable 1) 2018: 1 trials (Observational 1) 2019: 2 trials (Observational 1, Not applicable 1) 2020: 2 trials (Not applicable 2) 2021: 1 trials (Not applicable 1) 2022: 6 trials (Observational 3, Not applicable 3) 2023: 4 trials (Observational 1, Not applicable 3) 2024: 3 trials (Not applicable 3) 2025: 2 trials (Observational 1, Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 3
2025 2
2024 3
2023 4
2022 6
2021 1
2020 2
2019 2
2018 1
2015 1

No forecast is made for this condition: it averages 3.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Ankyloglossia trials in? (3)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1/2 1
Not applicable 22
Observational 8

How many Ankyloglossia trials are recruiting? (8)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 3
Recruiting 3
Enrolling by invitation 1
Active, not recruiting 3
Completed 16

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Ankyloglossia trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Europa Life Sciences Limited 2
Tel-Aviv Sourasky Medical Center 1

Which drugs are being tested for Ankyloglossia? (5)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Alfentanil 1
Esmeron 1
Bovine Colostrum 1
PROPOFOL 1
Lavender Oil 1

Interventions as named in the registry (4)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Sham Procedure 2
Double distilled water 1
Topical Benzocaine 1
Ibuprofen suppository 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Ankyloglossia? (27)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Does Lingual Frenotomy Improve Breastfeeding in Newborns With Ankyloglossia? A Randomized Controlled Trial. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2025 Yes
Ankyloglossia and Breastfeeding Duration: A Multicenter Birth Cohort Study. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine 2024 Yes
Comparison of the analgesic effect of inhaled lavender vs vanilla essential oil for neonatal frenotomy: a randomized clinical trial (NCT04867824). European journal of pediatrics 2022 Yes
The effect of ankyloglossia and tongue-tie division on speech articulation: A systematic review. International journal of paediatric dentistry 2022 Yes
Systematic review of the evidence for resolution of common breastfeeding problems-Ankyloglossia (Tongue Tie). Acta paediatrica (Oslo, Norway : 1992) 2022 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages